II
NUVB icon

Ishara Investments’s Nuvation Bio NUVB Stock Holding History

Ishara Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
+369,000
New +$1.8M 1.54% 24
2026
Q1 		– Sell
-400,000
Closed -$3.58M – 52
2025
Q4 		$3.58M Buy
+400,000
New +$2.48M 4.1% 7

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ishara Investments's NUVB Position: Q2 2026 in Review

Ishara Investments opened a new position in Nuvation Bio (NUVB) in Q2 2026: 369,000 shares worth $2.1M. The stake represents 1.54% of the portfolio and ranks #24 among its holdings. This is a return to the name: Ishara Investments previously reported a position in NUVB as recently as Q4 2025.

Ishara Investments first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.58M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Ishara Investments held 369,000 shares of Nuvation Bio worth $2.1M as of Q2 2026.
  • Nuvation Bio was a new Ishara Investments position in Q2 2026.
  • Nuvation Bio made up 1.54% of Ishara Investments's portfolio in Q2 2026, its #24 holding.
  • Ishara Investments first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • Ishara Investments's Nuvation Bio position peaked at $3.58M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Ishara Investments's 13F filing for Q2 2026, filed 14 Aug 2026.